Cirrhosis/Liver Failure

Top Story

NAFLD, NASH leading 'economic tsunami' of liver disease in US

July 22, 2019
Feature

AASLD Foundation presents grants to young hepatologists for research, careers

July 18, 2019
The American Association for the Study of Liver Diseases Foundation has granted $3.42 million in research and career development awards to 29 researchers and clinicians…

Dicerna readies alpha-1 antitrypsin deficiency-related liver disease drug for trial

July 2, 2019
Dicerna Pharmaceuticals submitted a clinical trial authorization application to the Swedish Medical Products Agency to conduct a phase 1/2 study of DCR-A1AT for the…

FDA grants fast track to alpha-1 antitrypsin deficiency-related liver disease drug

June 28, 2019
The FDA granted fast track designation to ARO-AAT, Arrowhead Pharmaceuticals’ second generation subcutaneously administered RNA interference therapeutic, for the…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

Expert reviews clinical liver disease take-aways from DDW 2018

June 5, 2018
More »